Perform Another (Advanced) Search

1.  CenterWatch: New Medical Therapies in Disease Category (5), Acute Rhinitis
...phase II trial of CDX-313 nasal spray for the treatment of seasonal allergic rhinitis (SAR). This randomized, double-blind, three-way cross-over study enrolled 108 subjects with SAR. The subjects received CDX-313 nasal spray (Budesonide + Azelastine), Rhinocort Aqua + Astelin Nasal Spray or ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (715), Allergies & Asthma
...phase II trial of CDX-313 nasal spray for the treatment of seasonal allergic rhinitis (SAR). This randomized, double-blind, three-way cross-over study enrolled 108 subjects with SAR. The subjects received CDX-313 nasal spray (Budesonide + Azelastine), Rhinocort Aqua + Astelin Nasal Spray or ...
View Page

3.  Study Posting (367) Trial #59677, Allergy (Pediatric), Louisville, KY
...Eligibility Criteria: • Ages 2 - 5. • Must have 1-year history of PAR with or without SAR, positive skin prick test to relevant perennial allergen. • No URI or sinus infection within 2 ...
View Page

4.  Newly Approved Drug Therapies (747) Clarinex, Schering-Plough,
...Clarinex, in an oral tablet formulation, was approved for the treatment of seasonal allergic rhinitis (SAR)in adults and children over 12 years of age in December 2001. In February 2002 ...
...most common allergic disorder in the United States, affecting up to 30% of the population.SAR is considered a response to outdoor allergens, while PAR pertains to indoor allergens. AR symptoms ...
View Page

5.  CenterWatch: New Medical Therapies in Disease Category (804), Rhinitis, Allergic, Perennial
...a phase III trial of epinastine nasal spray for the treatment of seasonal allergic rhinitis (SAR). This fourteen-day, randomized, double-blind trial enrolled seven hundred and ninety eight subjects with documented SAR during mountain cedar season in south central Texas. The subjects received epinastine (0.10% and ...
View Page

6.  CenterWatch: New Medical Therapies in Disease Category (166), Allergy
...a phase III trial of epinastine nasal spray for the treatment of seasonal allergic rhinitis (SAR). This fourteen-day, randomized, double-blind trial enrolled seven hundred and ninety eight subjects with documented SAR during mountain cedar season in south central Texas. The subjects received epinastine (0.10% and ...
View Page